Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Mar;83(3):986–993. doi: 10.1172/JCI113985

Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

S Adnot 1, P Andrivet 1, P E Chabrier 1, J Piquet 1, P Plas 1, P Braquet 1, F Roudot-Thoraval 1, C Brun-Buisson 1
PMCID: PMC303775  PMID: 2522105

Abstract

To investigate the physiological role of atrial natriuretic factor (ANF) in patients with hypoxic pulmonary hypertension secondary to chronic obstructive lung disease (COLD), we infused synthetic alpha-human ANF in seven such patients, and investigated the physiological correlates to circulating peptide levels in 24 patients with COLD. ANF infusion, at incremental rates of 0.01, 0.03, and 0.1 micrograms/kg.min, increased basal plasma immunoreactive (ir) ANF (136 +/- 38 pg/ml) by 3-, 10-, and 26-fold, respectively, and reduced pulmonary artery pressure (from 33 +/- 3 to 25 +/- 2 mmHg, P less than 0.001) and systemic arterial pressure (from 88 +/- 4 to 79 +/- 4 mmHg, P less than 0.001) in a dose-related fashion. Cardiac index increased by 13.5% (P less than 0.01) while heart rate was unchanged. Cardiac filling pressures decreased at 0.1 micrograms/kg.min ANF. Pulmonary and systemic vascular resistance fell by 37% (P less than 0.001) and 19% (P less than 0.001), respectively. Arterial oxygenation was impaired during ANF infusion, suggesting partial reversal of hypoxic pulmonary vasoconstriction. Plasma renin activity remained unchanged but aldosterone fell by 44% (P less than 0.01). The levels of plasma irANF in 24 patients correlated directly with the degree of hemoconcentration (r = 0.67, P less than 0.001), respiratory acidosis (r = -0.65, P less than 0.001), and pulmonary hypertension (r = 0.52, P less than 0.01). The results suggest that ANF may serve as a potent pulmonary vasodilator involved in the circulatory homeostasis of patients with COLD.

Full text

PDF
989

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adnot S., Chabrier P. E., Andrivet P., Viossat I., Piquet J., Brun-Buisson C., Gutkowska Y., Braquet P. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis. 1987 Oct;136(4):951–956. doi: 10.1164/ajrccm/136.4.951. [DOI] [PubMed] [Google Scholar]
  2. Adnot S., Chabrier P. E., Brun-Buisson C., Viossat I., Braquet P. Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia. J Appl Physiol (1985) 1988 Nov;65(5):1975–1983. doi: 10.1152/jappl.1988.65.5.1975. [DOI] [PubMed] [Google Scholar]
  3. Allen D. E., Gellai M. Cardioinhibitory effect of atrial peptide in conscious rats. Am J Physiol. 1987 Mar;252(3 Pt 2):R610–R616. doi: 10.1152/ajpregu.1987.252.3.R610. [DOI] [PubMed] [Google Scholar]
  4. Bianchi C., Gutkowska J., Thibault G., Garcia R., Genest J., Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry. 1985;82(5):441–452. doi: 10.1007/BF02450479. [DOI] [PubMed] [Google Scholar]
  5. Breuhaus B. A., Saneii H. H., Brandt M. A., Chimoskey J. E. Atriopeptin II lowers cardiac output in conscious sheep. Am J Physiol. 1985 Dec;249(6 Pt 2):R776–R780. doi: 10.1152/ajpregu.1985.249.6.R776. [DOI] [PubMed] [Google Scholar]
  6. Cantin M., Genest J. The heart and the atrial natriuretic factor. Endocr Rev. 1985 Spring;6(2):107–127. doi: 10.1210/edrv-6-2-107. [DOI] [PubMed] [Google Scholar]
  7. Chien Y. W., Frohlich E. D., Trippodo N. C. Atrial natriuretic peptide increases resistance to venous return in rats. Am J Physiol. 1987 May;252(5 Pt 2):H894–H899. doi: 10.1152/ajpheart.1987.252.5.H894. [DOI] [PubMed] [Google Scholar]
  8. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Currie M. G., Newman W. H. Evidence for alpha-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart. Biochem Biophys Res Commun. 1986 May 29;137(1):94–100. doi: 10.1016/0006-291x(86)91180-0. [DOI] [PubMed] [Google Scholar]
  10. De Léan A., Racz K., Gutkowska J., Nguyen T. T., Cantin M., Genest J. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology. 1984 Oct;115(4):1636–1638. doi: 10.1210/endo-115-4-1636. [DOI] [PubMed] [Google Scholar]
  11. Dietz J. R. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol. 1984 Dec;247(6 Pt 2):R1093–R1096. doi: 10.1152/ajpregu.1984.247.6.R1093. [DOI] [PubMed] [Google Scholar]
  12. ENSON Y., GIUNTINI C., LEWIS M. L., MORRIS T. Q., FERRER M. I., HARVEY R. M. THE INFLUENCE OF HYDROGEN ION CONCENTRATION AND HYPOXIA ON THE PULMONARY CIRCULATION. J Clin Invest. 1964 Jun;43:1146–1162. doi: 10.1172/JCI104999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Epstein M., Loutzenhiser R., Friedland E., Aceto R. M., Camargo M. J., Atlas S. A. Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans. J Clin Invest. 1987 Mar;79(3):738–745. doi: 10.1172/JCI112879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Farber M. O., Kiblawi S. S., Strawbridge R. A., Robertson G. L., Weinberger M. H., Manfredi F. Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease. J Lab Clin Med. 1977 Aug;90(2):373–380. [PubMed] [Google Scholar]
  15. Farber M. O., Roberts L. R., Weinberger M. H., Robertson G. L., Fineberg N. S., Manfredi F. Abnormalities of sodium and H2O handling in chronic obstructive lung disease. Arch Intern Med. 1982 Jul;142(7):1326–1330. [PubMed] [Google Scholar]
  16. Fishman A. P. State of the art: chronic cor pulmonale. Am Rev Respir Dis. 1976 Oct;114(4):775–794. doi: 10.1164/arrd.1976.114.4.775. [DOI] [PubMed] [Google Scholar]
  17. Fujita T., Ito Y., Noda H., Sato Y., Ando K., Kangawa K., Matsuo H. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. J Clin Invest. 1987 Sep;80(3):832–840. doi: 10.1172/JCI113141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ignarro L. J., Wood K. S., Harbison R. G., Kadowitz P. J. Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein. J Appl Physiol (1985) 1986 Apr;60(4):1128–1133. doi: 10.1152/jappl.1986.60.4.1128. [DOI] [PubMed] [Google Scholar]
  19. Jansen T. L., Morice A. H., Brown M. J. A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro. Br J Pharmacol. 1987 Jul;91(3):687–691. doi: 10.1111/j.1476-5381.1987.tb11263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lang R. E., Thölken H., Ganten D., Luft F. C., Ruskoaho H., Unger T. Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature. 1985 Mar 21;314(6008):264–266. doi: 10.1038/314264a0. [DOI] [PubMed] [Google Scholar]
  21. Lappe R. W., Smits J. F., Todt J. A., Debets J. J., Wendt R. L. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ Res. 1985 Apr;56(4):606–612. doi: 10.1161/01.res.56.4.606. [DOI] [PubMed] [Google Scholar]
  22. Laragh J. H. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985 Nov 21;313(21):1330–1340. doi: 10.1056/NEJM198511213132106. [DOI] [PubMed] [Google Scholar]
  23. Maack T., Marion D. N., Camargo M. J., Kleinert H. D., Laragh J. H., Vaughan E. D., Jr, Atlas S. A. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med. 1984 Dec;77(6):1069–1075. doi: 10.1016/0002-9343(84)90190-6. [DOI] [PubMed] [Google Scholar]
  24. McKenzie J. C., Tanaka I., Inagami T., Misono K. S., Klein R. M. Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc Soc Exp Biol Med. 1986 Mar;181(3):459–463. doi: 10.3181/00379727-181-rc3. [DOI] [PubMed] [Google Scholar]
  25. Needleman P., Adams S. P., Cole B. R., Currie M. G., Geller D. M., Michener M. L., Saper C. B., Schwartz D., Standaert D. G. Atriopeptins as cardiac hormones. Hypertension. 1985 Jul-Aug;7(4):469–482. doi: 10.1161/01.hyp.7.4.469. [DOI] [PubMed] [Google Scholar]
  26. Olins G. M., Patton D. R., Tjoeng F. S., Blehm D. J. Specific receptors for atriopeptin III in rabbit lung. Biochem Biophys Res Commun. 1986 Oct 15;140(1):302–307. doi: 10.1016/0006-291x(86)91090-9. [DOI] [PubMed] [Google Scholar]
  27. POLAK A., HAYNIE G. D., HAYS R. M., SCHWARTZ W. B. Effects of chronic hypercapnia on electrolyte and acid-base equilibrium. I. Adaptation. J Clin Invest. 1961 Jul;40:1223–1237. doi: 10.1172/JCI104353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Raine A. E., Erne P., Bürgisser E., Müller F. B., Bolli P., Burkart F., Bühler F. R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. doi: 10.1056/NEJM198608283150901. [DOI] [PubMed] [Google Scholar]
  29. Richards A. M., Nicholls M. G., Ikram H., Webster M. W., Yandle T. G., Espiner E. A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. doi: 10.1016/s0140-6736(85)91207-3. [DOI] [PubMed] [Google Scholar]
  30. Saito Y., Nakao K., Nishimura K., Sugawara A., Okumura K., Obata K., Sonoda R., Ban T., Yasue H., Imura H. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 1987 Jul;76(1):115–124. doi: 10.1161/01.cir.76.1.115. [DOI] [PubMed] [Google Scholar]
  31. Sanfield J. A., Shenker Y., Grekin R. J., Rosen S. G. Epinephrine increases plasma immunoreactive atrial natriuretic hormone levels in humans. Am J Physiol. 1987 Jun;252(6 Pt 1):E740–E745. doi: 10.1152/ajpendo.1987.252.6.E740. [DOI] [PubMed] [Google Scholar]
  32. Sasaki A., Kida O., Kangawa K., Matsuo H., Tanaka K. Involvement of sympathetic nerves in cardiosuppressive effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized rats. Eur J Pharmacol. 1986 Jan 29;120(3):345–349. doi: 10.1016/0014-2999(86)90475-9. [DOI] [PubMed] [Google Scholar]
  33. Schiebinger R. J., Baker M. Z., Linden J. Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. J Clin Invest. 1987 Dec;80(6):1687–1691. doi: 10.1172/JCI113258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Segel N., Bishop J. M. The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest. 1966 Oct;45(10):1555–1568. doi: 10.1172/JCI105462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shenker Y., Sider R. S., Ostafin E. A., Grekin R. J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest. 1985 Oct;76(4):1684–1687. doi: 10.1172/JCI112154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. TENNEY S. M. Sympatho-adrenal stimulation by carbon dioxide and the inhibitory effect of carbonic acid on epinephrine response. Am J Physiol. 1956 Nov;187(2):341–346. doi: 10.1152/ajplegacy.1956.187.2.341. [DOI] [PubMed] [Google Scholar]
  37. Tikkanen I., Fyhrquist F., Metsärinne K., Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet. 1985 Jul 13;2(8446):66–69. doi: 10.1016/s0140-6736(85)90178-3. [DOI] [PubMed] [Google Scholar]
  38. Trippodo N. C., Barbee R. W. Atrial natriuretic factor decreases whole-body capillary absorption in rats. Am J Physiol. 1987 May;252(5 Pt 2):R915–R920. doi: 10.1152/ajpregu.1987.252.5.R915. [DOI] [PubMed] [Google Scholar]
  39. Volpe M., Sosa R. E., Müller F. B., Camargo M. J., Glorioso N., Laragh J. H., Maack T., Atlas S. A. Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension. Am J Physiol. 1986 May;250(5 Pt 2):H871–H878. doi: 10.1152/ajpheart.1986.250.5.H871. [DOI] [PubMed] [Google Scholar]
  40. Waldhäusl W., Vierhapper H., Nowotny P. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis. J Clin Endocrinol Metab. 1986 May;62(5):956–959. doi: 10.1210/jcem-62-5-956. [DOI] [PubMed] [Google Scholar]
  41. Weidmann P., Hasler L., Gnädinger M. P., Lang R. E., Uehlinger D. E., Shaw S., Rascher W., Reubi F. C. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest. 1986 Mar;77(3):734–742. doi: 10.1172/JCI112368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Weisse A. B., Moschos C. B., Frank M. J., Levinson G. E., Cannilla J. E., Regan T. J. Hemodynamic effects of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels. Am J Med. 1975 Jan;58(1):92–98. doi: 10.1016/0002-9343(75)90538-0. [DOI] [PubMed] [Google Scholar]
  43. Weselcouch E. O., Humphrey W. R., Aiken J. W. Effect of pulmonary and renal circulations on activity of atrial natriuretic factor. Am J Physiol. 1985 Nov;249(5 Pt 2):R595–R602. doi: 10.1152/ajpregu.1985.249.5.R595. [DOI] [PubMed] [Google Scholar]
  44. Yamaji T., Ishibashi M., Takaku F. Atrial natriuretic factor in human blood. J Clin Invest. 1985 Oct;76(4):1705–1709. doi: 10.1172/JCI112159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES